Three-year experience with ziprasidone exposures

Frank LoVecchio; David Watts; P. Eckholdt

doi:10.1016/j.ajem.2004.09.033

Switch to Standard View Switch to Enhanced View

Three-year experience with ziprasidone exposures

Frank LoVecchio, DO, MPH

Banner Good Samaritan Regional Poison Center, Phoenix, AZ 85006, USA

Department of Emergency Medicine, Maricopa Medical Center, Phoenix, AZ 85006, USA

David Watts, MD

Banner Good Samaritan Regional Poison Center, Phoenix, AZ 85006, USA

Department of Emergency Medicine, Maricopa Medical Center, Phoenix, AZ 85006, USA

P. Eckholdt

Department of Emergency Medicine, Maricopa Medical Center, Phoenix, AZ 85006, USA

DOI: http://dx.doi.org/10.1016/j.ajem.2004.09.033

Purchase this article (PDF Included)

$31.50 USD (24 hour access)

Subscribe to this title

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

Ziprasidone (ZIP) is an atypical antipsychotic medication approved for treatment of schizophrenia, acute psychomotor agitation, and the treatment of bipolar disorder. Although the side effects of ZIP during standard clinical use are well described, there is a relative dearth of information regarding toxicity in either accidental ingestion or intentional overdose.

To access this article, please choose from the options below

Log In

Register

Create a new account

Purchase access to this article

$31.50 USD|Online access for 24 hours

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

Three-year experience with ziprasidone exposures

To access this article, please choose from the options below

Log In

Register

Purchase access to this article

Claim Access

Subscribe to this title

Institutional Access

Article Tools

Related Articles